Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) EBITDA Margin Growth (1y) (2011 - 2013)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3,609.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,536.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -957.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 8,807.00
10 Tenax Therapeutics 542.72 Mn 542.72 Mn - -

Historic Data

Download Data 🔒
DateValue
Apr 30, 2013 138,483.00
Jan 31, 2013 56,255.00
Oct 31, 2012 202,611.00
Jul 31, 2012 914,614.00
Apr 30, 2012 -821,948.00
Jan 31, 2012 -1.16 Mn
Oct 31, 2011 -974,089.00